Musculoskeletal Ultrasound in Asymptomatic Hyperuricemia
NCT02502565 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2018-06-19
Summary
An observational study to evaluate the prevalence of US changes of gout in the joints and tendons of patients with different degrees of asymptomatic hyperuricemia. The investigators' findings may support the extension of the spectrum of urate disease, and define a subset of patients that may benefit from early urate-lowering therapy.
Conditions
- Hyperuricemia
Interventions
- OTHER
-
Uric acid level
Sponsors & Collaborators
-
Howard University
collaborator OTHER - collaborator INDUSTRY
-
Washington D.C. Veterans Affairs Medical Center
lead FED
Principal Investigators
-
Gail S Kerr, MD, FRCP · Washington VAMC
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2019-01-31
- Completion
- 2019-03-31
Countries
- United States
Study Locations
More Related Trials
-
The Efficiency and Safety of Sodium Bicarbonate on Uric Acid in Patients With Asymptomatic Hyperuricemia or Gout
NCT03306758 ·Status: UNKNOWN ·Phase: NA
-
Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients
NCT00675103 ·Status: COMPLETED ·Phase: PHASE3
-
Research and Development of a New Technology for Detection of Abnormal Excretion of Intestinal Uric Acid Involved in the Incidence of Gout
NCT04953533 ·Status: UNKNOWN
-
DECT Study in Allopurinol-Treated Gout Patients
NCT02393560 ·Status: COMPLETED
-
Purine Metabolism Enzyme SNP to Uric Acid Production
NCT01830725 ·Status: COMPLETED
-
Study of URC102 to Assess the Safety and Efficacy in Gout Patients
NCT02557126 ·Status: COMPLETED ·Phase: PHASE2
-
Genetics of Hyperuricemia Therapy in Hmong
NCT02371421 ·Status: COMPLETED
-
Tolerance, Pharmacokinetics / Pharmacodynamics (PK / PD) and Immunogenicity of Pegylated Uric Acid Oxidase for Injection in Healthy Adults and Hyperuricemia Volunteers
NCT05226013 ·Status: UNKNOWN ·Phase: PHASE1
-
The Diet Gout Trial
NCT03569020 ·Status: COMPLETED ·Phase: NA
-
Hyperuricemia and Diabetic Nephropathy
NCT04799925 ·Status: UNKNOWN
-
A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy
NCT00080210 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia
NCT06056570 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Allopurinol on Inflammation and Ultrasonographic Changes in People With Elevated Uric Acid But no Symptoms
NCT04012294 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Dotinurad Versus Allopurinol in Participants With Gout
NCT07089875 ·Status: RECRUITING ·Phase: PHASE3
-
Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With Gout
NCT05546593 ·Status: RECRUITING
-
Gout Self-Monitoring Aiming to Reach Target
NCT03274063 ·Status: COMPLETED ·Phase: NA
-
A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout
NCT02287818 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperuricemia on Hypertension and Metabolic Syndrome
NCT01157936 ·Status: COMPLETED ·Phase: PHASE2
-
Study of FYU-981 in Hyperuricemia With or Without Gout
NCT02344862 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout
NCT00325195 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of SSGJ-613 in Gout Subjects Initiating Urate-Lowering Treatment.
NCT06270225 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Prospective Cohort Study of China Serum Uric Acid Levels
NCT03616769 ·Status: COMPLETED
-
Evaluating the Effectiveness of a Chronic Disease Management Program for Gout
NCT01568879 ·Status: COMPLETED ·Phase: NA
-
Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect
NCT02598596 ·Status: COMPLETED ·Phase: PHASE2
-
Improving Gout Care After an ED Visit
NCT06534554 ·Status: RECRUITING ·Phase: NA